Skip to main content

Chung-Che J. Chang, MD, PhD, FCAP

Chung-Che J. Chang , MD, PhD, FCAP

Pathologist

Cancer

Overview

Articles

Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

2023

Clinicopathologic Features of Lymphoproliferative Neoplasms Involving the Liver

MEDICINA-LITHUANIA

2022

Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature

MODERN PATHOLOGY

2022

Mutational profiling of myeloid neoplasms associated genes may aid the diagnosis of acute myeloid leukemia with myelodysplasia-related changes

LEUKEMIA RESEARCH

2021

Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective

TRANSPLANTATION AND CELLULAR THERAPY

2021

Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by NPM1 Mutation

DIAGNOSTICS

2021

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

FRONTIERS IN ONCOLOGY

2021

Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy

CLINICAL LUNG CANCER

2021

Local ALK-Positive Histiocytosis With Unusual Morphology and Novel TRIM33-ALK Gene Fusion

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

2020

Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma

CLINICAL LUNG CANCER

2020

Education & Training

Education

National Yan-Ming Medical College, Shipai, Beitou District, Taipei, Taiwan

Residency

Metrohealth Medical Center, Cleveland, OH

Board Certifications

American Board of Pathology

Associated Clinical Trials